DEA pharmacy take-back receptacles: secure handling and disposal

A retail pharmacy may operate a controlled-substance collection receptacle only as a DEA-authorized collector and under the applicable safeguards. The receptacle must prevent public access to collected drugs, and a sealed inner liner must never be opened, sorted, or inventoried after removal.

A take-back kiosk is not an ordinary trash bin

DEA regulations allow certain registrants, including authorized retail pharmacies, to collect unwanted pharmaceutical controlled substances from ultimate users and household members. A pharmacy must be authorized as a collector and follow 21 CFR Part 1317 and any state requirements. A public collection receptacle is designed for consumers to deposit eligible medicines; it is not a way for a pharmacy to discard its own controlled-substance inventory or pharmaceutical wastage remaining after administration. Those situations follow separate disposal rules. Before accepting a receptacle, the pharmacy should confirm authorization, location, access controls, staff responsibilities, and downstream destruction arrangements.

Secure outer container and limited access

The collection receptacle’s outer container must be securely fixed and substantially constructed so it cannot be readily removed. Its opening must allow deposits without allowing the public to retrieve the inner liner or contents. The receptacle must display what may be deposited and exclude Schedule I substances, illicit substances, and other prohibited materials. When an employee is not present or the receptacle is not regularly monitored, the deposit opening must be locked or made inaccessible to the public, subject to specific exceptions for certain locations. Place the kiosk where staff can monitor it without compromising patient privacy or safe workflow. Never leave a loose liner or unlocked receptacle accessible to visitors.

Inner liner requirements

The inner liner is the controlled container for the collected medications. It must be waterproof, tamper-evident, tear-resistant, removable and sealable immediately without emptying or touching the contents, and opaque when sealed. The liner has a unique tracking number and a marked capacity. These features preserve chain of custody and help identify a missing or tampered liner. When the liner is full or being removed, authorized employees follow the required procedure, seal it immediately, record the event, and transfer it to an authorized destruction route. Do not open the liner to make room, inspect medication labels, or remove an item that a consumer deposited in error.

Two-person installation and removal

DEA rules require installation and removal of the inner liner to be performed by or under the supervision of at least two employees of the authorized collector. A special staffing framework applies to collection receptacles located at long-term-care facilities, where the collector and facility must coordinate the specified employees. The process should include checking the liner identifier, documenting date and time, inspecting seals and container condition, and maintaining custody during transfer. Follow the collector’s written procedures and record any irregularity. A technician may assist if trained and authorized, but should not perform the controlled-custody task alone when the two-person rule applies.

Never sort or count the contents

Once medication is deposited into the collection receptacle, staff must not sort, inventory, or count the individual contents. After removal, the liner is sealed and remains sealed. DEA explains that an authorized collector does not file a Form 106 for the unobservable contents if a sealed liner is stolen or lost; the collector reports the missing liner itself under the applicable rules. This is why the liner number and secure custody matter. A pharmacy should record the liner’s identifying information and handoff, not try to reconstruct each consumer’s deposit. A missing liner is serious: preserve evidence, secure the area, promptly notify the designated compliance lead, and follow DEA and state reporting requirements.

Disposal of pharmacy inventory is different

Controlled substances in a pharmacy’s registrant inventory cannot be disposed of through a public take-back collection receptacle. A DEA registrant must use an authorized disposal process, such as transfer to a reverse distributor, on-site destruction by an authorized method, or another method permitted under Part 1317. Likewise, leftover controlled medication in a syringe, vial, patch, or other dosage form after patient administration is pharmaceutical wastage and is not a public take-back deposit. Staff should follow the facility’s documented wastage and disposal rules. This distinction protects chain of custody and prevents a public collection stream from mixing with the pharmacy’s controlled inventory.

PTCE scenario and safe workflow

A customer asks a technician to open a kiosk because a tablet bottle was dropped inside. The technician should not open or retrieve the medicine. A pharmacist or trained authorized employee follows the collector’s procedure; the public cannot access the liner contents, and any liner installation or removal requires the specified two-person supervision. If a liner is missing or appears tampered with, secure the area and escalate immediately. For exam questions, identify the authorized collector, secure outer container, sealed inner liner, two-person process, no sorting or inventory of contents, and distinction between public returns and pharmacy-owned stock. State and local rules can add requirements.

A practical verification point

Collectors should also follow the receptacle sign and accepted-substance rules: Schedule II–V and noncontrolled medicines may be accepted when the collector chooses to commingle them, but Schedule I drugs and illicit or dangerous materials are not permitted. Public mail-back programs and law-enforcement events are alternative collection methods with their own safeguards. A customer should not be asked to open packaging at the kiosk or identify the contents after deposit; the system is designed to protect privacy and prevent diversion.

How to approach an exam scenario

Start by identifying the specific rule, medication phase, or coverage stage in the question. Separate what a technician can collect and document from the pharmacist’s clinical or legal decision. Apply the rule to the dates, order details, and authorized workflow provided. When a detail varies by state or by product, use the current primary source and escalate rather than making an assumption.